Connective tissue growth factor promotes temozolomide resistance in glioblastoma through TGF-β1-dependent activation of Smad/ERK signaling
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Connective tissue growth factor promotes temozolomide resistance in glioblastoma through TGF-β1-dependent activation of Smad/ERK signaling
Authors
Keywords
-
Journal
Cell Death & Disease
Volume 8, Issue 6, Pages e2885
Publisher
Springer Nature
Online
2017-06-15
DOI
10.1038/cddis.2017.248
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer stem cell metabolism: a potential target for cancer therapy
- (2016) Abhijeet Deshmukh et al. Molecular Cancer
- Dedifferentiation of Glioma Cells to Glioma Stem-like Cells By Therapeutic Stress-induced HIF Signaling in the Recurrent GBM Model
- (2016) Gina Lee et al. MOLECULAR CANCER THERAPEUTICS
- Cancer stem cell mediated acquired chemoresistance in head and neck cancer can be abrogated by aldehyde dehydrogenase 1 A1 inhibition
- (2016) Safeena Kulsum et al. MOLECULAR CARCINOGENESIS
- Cancer stem cells and chemoresistance: The smartest survives the raid
- (2016) Jihe Zhao PHARMACOLOGY & THERAPEUTICS
- Targeting cancer stem cell-specific markers and/or associated signaling pathways for overcoming cancer drug resistance
- (2016) Peyman Ranji et al. TUMOR BIOLOGY
- Temozolomide competes for P-glycoprotein and contributes to chemoresistance in glioblastoma cells
- (2015) Jessian L. Munoz et al. CANCER LETTERS
- TGF-β Promotes Heterogeneity and Drug Resistance in Squamous Cell Carcinoma
- (2015) Naoki Oshimori et al. CELL
- Ionizing radiation induces a motile phenotype in human carcinoma cells in vitro through hyperactivation of the TGF-beta signaling pathway
- (2015) Cedric Carl et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Cellular and molecular actions of CCN2/CTGF and its role under physiological and pathological conditions
- (2015) Satoshi Kubota et al. CLINICAL SCIENCE
- The role of glioma stem cells in chemotherapy resistance and glioblastoma multiforme recurrence
- (2015) Brenda Auffinger et al. Expert Review of Neurotherapeutics
- Rapamycin increases CCN2 expression of lung fibroblasts via phosphoinositide 3-kinase
- (2015) Xuefeng Xu et al. LABORATORY INVESTIGATION
- Targeting miR-381-NEFL axis sensitizes glioblastoma cells to temozolomide by regulating stemness factors and multidrug resistance factors
- (2015) Zeyou Wang et al. Oncotarget
- The role of glioma stem cells in chemotherapy resistance and glioblastoma multiforme recurrence
- (2015) Brenda Auffinger et al. Expert Review of Neurotherapeutics
- CTGF increases drug resistance to paclitaxel by upregulating survivin expression in human osteosarcoma cells
- (2014) Hsiao-Chi Tsai et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Conversion of differentiated cancer cells into cancer stem-like cells in a glioblastoma model after primary chemotherapy
- (2014) B Auffinger et al. CELL DEATH AND DIFFERENTIATION
- Osteopontin-CD44 Signaling in the Glioma Perivascular Niche Enhances Cancer Stem Cell Phenotypes and Promotes Aggressive Tumor Growth
- (2014) Alexander Pietras et al. Cell Stem Cell
- Deregulated expression of connective tissue growth factor (CTGF/CCN2)is linked to poor outcome in human cancer
- (2014) Julia E. Wells et al. INTERNATIONAL JOURNAL OF CANCER
- Cyr61 promotes epithelial-mesenchymal transition and tumor metastasis of osteosarcoma by Raf-1/MEK/ERK/Elk-1/TWIST-1 signaling pathway
- (2014) Chun-Han Hou et al. Molecular Cancer
- miR-125b controls apoptosis and temozolomide resistance by targeting TNFAIP3 and NKIRAS2 in glioblastomas
- (2014) S Haemmig et al. Cell Death & Disease
- Connective Tissue Growth Factor Activates Pluripotency Genes and Mesenchymal–Epithelial Transition in Head and Neck Cancer Cells
- (2013) Cheng-Chi Chang et al. CANCER RESEARCH
- TGF-β: An emerging player in drug resistance
- (2013) Diede Brunen et al. CELL CYCLE
- Transforming growth factor β induces expression of connective tissue growth factor in hepatic progenitor cells through Smad independent signaling
- (2013) Ze-yang Ding et al. CELLULAR SIGNALLING
- Transforming Growth Factor-β (TGF-β)-mediated Connective Tissue Growth Factor (CTGF) Expression in Hepatic Stellate Cells Requires Stat3 Signaling Activation
- (2013) Yan Liu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- O6-methylguanine DNA methyltransferase as a promising target for the treatment of temozolomide-resistant gliomas
- (2013) C-H Fan et al. Cell Death & Disease
- Targeting of TGF signature and its essential component CTGF by miR-18 correlates with improved survival in glioblastoma
- (2012) J. L. Fox et al. RNA
- Current concepts and management of glioblastoma
- (2011) Matthias Preusser et al. ANNALS OF NEUROLOGY
- CTGF is overexpressed in malignant melanoma and promotes cell invasion and migration
- (2011) S Braig et al. BRITISH JOURNAL OF CANCER
- Chemoresistance of glioblastoma cancer stem cells - much more complex than expected
- (2011) Dagmar Beier et al. Molecular Cancer
- Stem cell marker (Nanog) and Stat-3 signaling promote MicroRNA-21 expression and chemoresistance in hyaluronan/CD44-activated head and neck squamous cell carcinoma cells
- (2011) L Y W Bourguignon et al. ONCOGENE
- Connective tissue growth factor modulates oral squamous cell carcinoma invasion by activating a miR-504/FOXP1 signalling
- (2011) M-H Yang et al. ONCOGENE
- CTGF is overexpressed in papillary thyroid carcinoma and promotes the growth of papillary thyroid cancer cells
- (2011) Lei Cui et al. TUMOR BIOLOGY
- Connective tissue growth factor associated with oncogenic activities and drug resistance in glioblastoma multiforme
- (2010) Dong Yin et al. INTERNATIONAL JOURNAL OF CANCER
- Aldehyde dehydrogenase 1 positive glioblastoma cells show brain tumor stem cell capacity
- (2010) M. Rasper et al. NEURO-ONCOLOGY
- EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer
- (2010) A Singh et al. ONCOGENE
- Connective Tissue Growth Factor Confers Drug Resistance in Breast Cancer through Concomitant Up-regulation of Bcl-xL and cIAP1
- (2009) M.-Y. Wang et al. CANCER RESEARCH
- Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
- (2009) Roger Stupp et al. LANCET ONCOLOGY
- Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features
- (2009) C. J. Creighton et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Non-Smad pathways in TGF-β signaling
- (2008) Ying E Zhang CELL RESEARCH
- Mechanisms of Chemoresistance to Alkylating Agents in Malignant Glioma
- (2008) J. N. Sarkaria et al. CLINICAL CANCER RESEARCH
- Connective tissue growth factor (CTGF) and cancer progression
- (2008) Chia-Yu Chu et al. JOURNAL OF BIOMEDICAL SCIENCE
- Regulation of CCN2 mRNA expression and promoter activity in activated hepatic stellate cells
- (2008) Andrew Leask et al. Journal of Cell Communication and Signaling
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started